Prodeon Medical Announces Enrollment Completion for Expander-2 Pivotal Trial
January 7, 2025
Prodeon Medical, a medical device company developing a minimally invasive treatment for lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH), today announced